These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3012833)

  • 21. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation.
    Wingard JR; Chen DY; Burns WH; Fuller DJ; Braine HG; Yeager AM; Kaiser H; Burke PJ; Graham ML; Santos GW
    Blood; 1988 May; 71(5):1432-7. PubMed ID: 2833959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up.
    Ljungman P; Lönnqvist B; Wahren B; Ringdén O; Gahrton G
    Transplantation; 1985 Nov; 40(5):515-20. PubMed ID: 2997952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.
    Gratama JW; Oosterveer MA; Lepoutre JM; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Richel D; Klein G; Ernberg I
    Transplantation; 1990 Apr; 49(4):725-30. PubMed ID: 2158159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
    Boland GJ; Vlieger AM; Ververs C; De Gast GC
    Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection.
    Dolstra H; Preijers F; Van de Wiel-van Kemenade E; Schattenberg A; Galama J; de Witte T
    Br J Haematol; 1995 Jun; 90(2):300-7. PubMed ID: 7540855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization.
    Link H; Battmer K; Stumme C
    Br J Haematol; 1993 Nov; 85(3):573-7. PubMed ID: 8136281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients.
    Finny GJ; Mathews V; Abraham P; Abraham M; Chandy M; Srivastava A; Nitsche A; Siegert W; Sridharan G
    Indian J Med Res; 2001 Aug; 114():39-46. PubMed ID: 11785448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses].
    Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP
    Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
    Hammarström V; Pauksen K; Azinge J; Oberg G; Ljungman P
    Support Care Cancer; 1993 Jul; 1(4):195-9. PubMed ID: 8193881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation.
    de Gast GC; Gratama JW; Verdonck LF; van Heugten JG; Zwaan FE; Phillips DI; Mudde GC
    Transplantation; 1989 Jul; 48(1):111-5. PubMed ID: 2546299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpesvirus infections in the immunocompromised patient.
    Skinhøj P
    Scand J Infect Dis Suppl; 1985; 47():121-7. PubMed ID: 3006227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipient.
    Kato S; Yabe H; Yabe M; Kimura M; Ito M; Tsuchida F; Tsuji K; Takahashi M
    Blood; 1990 Feb; 75(3):806-9. PubMed ID: 2153426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship.
    Takemoto Y; Takatsuka H; Wada H; Mori A; Saheki K; Okada M; Tamura S; Fujimori Y; Okamoto T; Kakishita E; Kanamaru A
    Bone Marrow Transplant; 2000 Jul; 26(1):77-81. PubMed ID: 10918408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
    Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.
    Ljungman P; Wahren B; Sundqvist VA
    J Virol Methods; 1985 Dec; 12(3-4):199-208. PubMed ID: 2422193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.